PPARG and colorectal carcinoma: Our findings indicate that PGC1α collaborates with PPARγ to inhibit the Wnt-signaling pathway, suppress glycolytic enzyme PKM2 expression, diminish glycolysis and proliferation, and enhanced the efficacy of immune checkpoint inhibitors in CRC cells.